- Home
- AIT vs ROIV Comparison
AIT vs ROIV Comparison
Compare AIT & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIT
- ROIV
- Stock Information
- Founded
- AIT 1923
- ROIV 2014
- Country
- AIT United States
- ROIV United Kingdom
- Employees
- AIT N/A
- ROIV N/A
- Industry
- AIT Industrial Machinery/Components
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- AIT Industrials
- ROIV Health Care
- Exchange
- AIT Nasdaq
- ROIV Nasdaq
- Market Cap
- AIT 9.2B
- ROIV 7.8B
- IPO Year
- AIT N/A
- ROIV N/A
- Fundamental
- Price
- AIT $245.00
- ROIV $10.99
- Analyst Decision
- AIT Strong Buy
- ROIV Buy
- Analyst Count
- AIT 8
- ROIV 4
- Target Price
- AIT $283.75
- ROIV $17.50
- AVG Volume (30 Days)
- AIT 707.7K
- ROIV 7.3M
- Earning Date
- AIT 08-14-2025
- ROIV 08-07-2025
- Dividend Yield
- AIT 0.75%
- ROIV N/A
- EPS Growth
- AIT 4.74
- ROIV N/A
- EPS
- AIT 9.98
- ROIV N/A
- Revenue
- AIT $4,499,369,000.00
- ROIV $29,053,000.00
- Revenue This Year
- AIT $2.09
- ROIV $2.64
- Revenue Next Year
- AIT $5.97
- ROIV $378.09
- P/E Ratio
- AIT $24.62
- ROIV N/A
- Revenue Growth
- AIT 0.50
- ROIV N/A
- 52 Week Low
- AIT $182.21
- ROIV $8.73
- 52 Week High
- AIT $282.98
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- AIT 64.33
- ROIV 44.75
- Support Level
- AIT $230.44
- ROIV $10.83
- Resistance Level
- AIT $235.44
- ROIV $11.82
- Average True Range (ATR)
- AIT 5.98
- ROIV 0.32
- MACD
- AIT 1.81
- ROIV -0.07
- Stochastic Oscillator
- AIT 94.37
- ROIV 16.24
About AIT Applied Industrial Technologies Inc.
Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.